Efficacy and safety of imeglimin add‐on to insulin monotherapy in Japanese patients with type 2 diabetes ( TIMES 3): A randomized, double‐blind, placebo‐controlled phase 3 trial with a 36‐week open‐label extension period

Diabetes Obesity and Metabolism ◽

10.1111/dom.14642 ◽

2022 ◽

Author(s):

Caroline Reilhac ◽

Julie Dubourg ◽

Carole Thang ◽

Jean‐Marie Grouin ◽

Pascale Fouqueray ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension ◽

Extension Period

Download Full-text

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2012.00226.x ◽

2012 ◽

Vol 3 (6) ◽

pp. 517-525 ◽

Cited By ~ 24

Author(s):

Yutaka Seino ◽

Shinzo Hiroi ◽

Masashi Hirayama ◽

Kohei Kaku

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2017.1359259 ◽

2017 ◽

Vol 18 (13) ◽

pp. 1291-1300 ◽

Cited By ~ 16

Author(s):

Takashi Kadowaki ◽

Kazuoki Kondo ◽

Noriyuki Sasaki ◽

Kyoko Miyayama ◽

Shoko Yokota ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12235 ◽

2013 ◽

Vol 16 (5) ◽

pp. 418-425 ◽

Cited By ~ 32

Author(s):

T. Kadowaki ◽

K. Kondo

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01460.x ◽

2011 ◽

Vol 13 (11) ◽

pp. 1028-1035 ◽

Cited By ~ 51

Author(s):

K. Kaku ◽

T. Itayasu ◽

S. Hiroi ◽

M. Hirayama ◽

Y. Seino

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2017.1379990 ◽

2017 ◽

Vol 18 (18) ◽

pp. 1903-1919 ◽

Cited By ~ 4

Author(s):

Takashi Kadowaki ◽

Satsuki Muto ◽

Yoshiumi Ouchi ◽

Ryutaro Shimazaki ◽

Yutaka Seino

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Randomized Controlled ◽

Open Label Extension

Download Full-text

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study

Diabetology International ◽

10.1007/s13340-018-0359-x ◽

2018 ◽

Vol 10 (1) ◽

pp. 37-50 ◽

Cited By ~ 3

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Seitaro Asahina ◽

Taishi Sakatani

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Double Blind Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Open Label Extension

Download Full-text

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

Current Medical Research and Opinion ◽

10.1185/03007995.2014.912983 ◽

2014 ◽

Vol 30 (7) ◽

pp. 1245-1255 ◽

Cited By ~ 64

Author(s):

Yutaka Seino ◽

Takashi Sasaki ◽

Atsushi Fukatsu ◽

Michito Ubukata ◽

Soichi Sakai ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2012.01620.x ◽

2012 ◽

Vol 14 (10) ◽

pp. 927-936 ◽

Cited By ~ 39

Author(s):

Y. Seino ◽

Y. Miyata ◽

S. Hiroi ◽

M. Hirayama ◽

K. Kaku

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Decision letter for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v1/review2 ◽

2019 ◽

Author(s):

Bastiaan E de Galan

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text